Search details
1.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38832989
2.
Sperm mitochondria dysfunction in response to testicular cancer.
Eur J Clin Invest
; 54(4): e14146, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38069497
3.
Fecal miRNA profiles in colorectal cancers with mucinous morphology.
Mutagenesis
; 2024 Jun 06.
Article
in English
| MEDLINE | ID: mdl-38843106
4.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36858721
5.
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
Int J Cancer
; 153(6): 1241-1250, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37294085
6.
Favorable prognostic significance of membranous ß-catenin expression and negative prognostic significance of cytoplasmic ß-catenin expression in pancreatic cancer.
Neoplasma
; 70(6): 796-803, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38247336
7.
Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
Carcinogenesis
; 42(3): 378-394, 2021 04 17.
Article
in English
| MEDLINE | ID: mdl-33319241
8.
Mutational landscape of plasma cell-free DNA identifies molecular features associated with therapeutic response in patients with colon cancer. A pilot study.
Mutagenesis
; 36(5): 358-368, 2021 10 06.
Article
in English
| MEDLINE | ID: mdl-34214148
9.
Expression quantitative trait loci in ABC transporters are associated with survival in 5-FU treated colorectal cancer patients.
Mutagenesis
; 35(3): 273-281, 2020 07 11.
Article
in English
| MEDLINE | ID: mdl-31922572
10.
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Eur J Clin Microbiol Infect Dis
; 38(10): 1891-1899, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31367996
11.
Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients.
Genes Chromosomes Cancer
; 57(2): 61-69, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29052312
12.
MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.
Clin Chem Lab Med
; 56(9): 1426-1431, 2018 08 28.
Article
in English
| MEDLINE | ID: mdl-29451857
13.
Functional Polymorphisms in DNA Repair Genes Are Associated with Sporadic Colorectal Cancer Susceptibility and Clinical Outcome.
Int J Mol Sci
; 20(1)2018 Dec 27.
Article
in English
| MEDLINE | ID: mdl-30591675
14.
Simulations of centriole of polarized centrosome as a monopole antenna in immune and viral synapses.
J BUON
; 23(2): 514-521, 2018.
Article
in English
| MEDLINE | ID: mdl-29745101
15.
Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
Carcinogenesis
; 38(1): 28-39, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27803053
16.
The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.
Tumour Biol
; 39(7): 1010428317709283, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28714375
17.
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry.
BMC Cancer
; 17(1): 880, 2017 12 21.
Article
in English
| MEDLINE | ID: mdl-29268716
18.
MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Mutagenesis
; 32(5): 533-542, 2017 10 17.
Article
in English
| MEDLINE | ID: mdl-29048575
19.
Association of the combined parameters including the frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression with the outcome in intestinal cancer.
J BUON
; 22(6): 1477-1487, 2017.
Article
in English
| MEDLINE | ID: mdl-29332341
20.
[AR-V7 Androgen Receptor Variant as a Predictor of Response to Androgen-receptor Targeting Agents Used to Treat Castration-refractory Metastatic Prostate Cancer]. / Testování varianty androgenového receptoru AR-V7 pro výber pacientu s kastracne refrakterním metastazujícím karcinomem prostaty k lécbe novými hormonálními léky.
Klin Onkol
; 31(1): 9-14, 2017.
Article
in Czech
| MEDLINE | ID: mdl-29488772